CRP capture/detection of gram positive bacteria

US10513546B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10513546-B2
Application numberUS-201415105298-A
CountryUS
Kind codeB2
Filing dateDec 18, 2014
Priority dateDec 18, 2013
Publication dateDec 24, 2019
Grant dateDec 24, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are engineered microbe-targeting molecules, microbe-targeting articles, kits comprising the same, and uses thereof. Such microbe-targeting molecules, microbe-targeting articles, or the kits comprising the same can bind or capture of a microbe or microbial matter thereof, and can thus be used in various applications, such as diagnosis or treatment of an infection caused by microbes in a subject or any environmental surface.

First claim

Opening claim text (preview).

What is claimed is: 1. An assay for determining the presence or absence of a microbe in a test sample, the assay comprising: (i) contacting a test sample with a microbe-targeting molecule; and (ii) detecting binding of a microbe to the microbe-targeting molecule, wherein said detecting comprises contacting the sample from (i) with a labeling molecule comprising a detectable label that is conjugated to a c-reactive protein or a microbe binding portion thereof, and wherein a microbe is present in the test sample if binding is detected, and wherein the microbe-targeting molecule comprises: a. at least one first domain comprising at least a portion of a c-reactive protein (CRP); b. at least one second domain comprising at least a portion of a domain selected from the group consisting of: (i) Fc region of an immunoglobulin; (ii) microbe-binding domain of a microbe-binding protein, wherein the microbe-binding protein is not CRP; (ii) neck region of a lectin; (iv) a detectable label; (v) domain for conjugation to surface of a carrier scaffold; (vi) pattern recognition receptor domain of CRP; and (vii) any combinations of (i)-(vi); and a linker conjugating the first and second domains, and wherein the molecule is a multimeric molecule. 2. The assay of claim 1 , wherein the multimeric molecule is formed by interactions between the linkers of different molecules forming the multimeric molecule, or the linker and the second domain of different molecules forming the multimeric molecule, or the second domains of different molecules forming the multimeric molecule. 3. An assay for determining the presence or absence of a microbe in a test sample, the assay comprising: (i) contacting a test sample with a microbe-targeting molecule; and (ii) detecting binding of a microbe to the microbe-targeting molecule, wherein said detecting comprises contacting the sample from (i) with a labeling molecule comprising a detectable label that is conjugated to a c-reactive protein or a microbe binding portion thereof, and wherein a microbe is present in the test sample if binding is detected, and wherein the microbe-targeting molecule comprises: a. at least one first domain comprising at least a portion of a c-reactive protein (CRP); b. at least one second domain comprising at least a portion of a domain selected from the group consisting of: (i) Fc region of an immunoglobulin; (ii) microbe-binding domain of a microbe-binding protein, wherein the microbe-binding protein is not CRP; (ii) neck region of a lectin; (iv) a detectable label; (v) domain for conjugation to surface of a carrier scaffold; (vi) pattern recognition receptor domain of CRP; and (vii) any combinations of (i)-(vi); and a linker conjugating the first and second domains, and wherein the domain for conjugation to surface of a carrier scaffold comprises an amino group, a N-substituted amino group, a carboxyl group, a carbonyl group, an acid anhydride group, an aldehyde group, a hydroxyl group, an epoxy group, a thiol, a disulfide group, an alkenyl group, a hydrazine group, a hydrazide group, a semicarbazide group, a thiosemicarbazide group, one partner of a binding pair, an amide group, an aryl group, an ester group, an ether group, a glycidyl group, a halo group, a hydride group, an isocyanate group, an urea group, or an urethane group. 4. An assay for determining the presence or absence of a microbe in a test sample, the assay comprising: (i) contacting a test sample with a microbe-targeting molecule; and (ii) detecting binding of a microbe to the microbe-targeting molecule, wherein said detecting comprises contacting the sample from (i) with a labeling molecule comprising a detectable label that is conjugated to a c-reactive protein or a microbe binding portion thereof, and wherein a microbe is present in the test sample if binding is detected, and wherein the microbe-targeting molecule comprises: a. at least one first domain comprising at least a portion of a c-reactive protein (CRP); b. at least one second domain comprising at least a portion of a domain selected from the group consisting of: (i) Fc region of an immunoglobulin; (ii) microbe-binding domain of a microbe-binding protein, wherein the microbe-binding protein is not CRP; (ii) neck region of a lectin; (iv) a detectable label; (v) domain for conjugation to surface of a carrier scaffold; (vi) pattern recognition receptor domain of CRP; and (vii) any combinations of (i)-(vi); and a linker conjugating the first and second domains, and wherein the microbe-targeting molecule is conjugated to a surface of a carrier scaffold. 5. The assay of claim 4 , wherein the carrier scaffold is selected from the group consisting of a nucleic acid scaffold, a protein scaffold, a lipid scaffold, a polymeric scaffold, a dendrimer, a particle, a bead, a nanotube, a microtiter plate, a medical apparatus or implant, a microchip, a filtration device, a membrane, a diagnostic strip, a dipstick, an extracorporeal device, a spiral mixer, a hollow-fiber tube, a living cell, magnetic material, hollow fiber, and any combinations thereof.

Assignees

Inventors

Classifications

  • Immunoglobulins · CPC title

  • G01N33/569Primary

    for microorganisms, e.g. protozoa, bacteria, viruses · CPC title

  • Lectins · CPC title

  • C-reactive protein · CPC title

  • Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10513546B2 cover?
Described herein are engineered microbe-targeting molecules, microbe-targeting articles, kits comprising the same, and uses thereof. Such microbe-targeting molecules, microbe-targeting articles, or the kits comprising the same can bind or capture of a microbe or microbial matter thereof, and can thus be used in various applications, such as diagnosis or treatment of an infection caused by micro…
Who is the assignee on this patent?
Harvard College
What technology area does this patent fall under?
Primary CPC classification G01N33/569. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).